Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Growth Hormone Administration in Patients With Chronic Heart Failure and Low IGF-1 Levels

NCT01235273 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT01235273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01235273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Growth Hormone Administration in Patients With Chronic Heart Failure and Low IGF-1 Levels
Lead sponsor
Federico II University
Phase
Phase 2
Overall status
Suspended
Start date
January 31, 2011
Completion date
February 28, 2014
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure